no news_id given

Cyprus/Greece/MaltaCyprusGreeceMalta

29.01.2006

Crete - Using an implanted device to make the heart beat faster in pacemaker patients with obstructive sleep apnea-hypopnea syndrome does not help, according to a study of Greek researchers. The physicians around Professor Panos...

Cyprus/Greece/MaltaCyprusGreeceMalta

26.11.2005

Nicosia - A rare medical condition has been found to be nine times more prevalent in Cypriots living in Paphos than in the rest of Cyprus or the European Union. Results of research carried out by the Neurology and Genetic...

Cyprus/Greece/MaltaCyprusGreeceMalta

26.11.2005

Brussels - The European Union's Agricultural Council has failed to reach a qualified majority for rejecting or upholding the Greek ban on genetically modified (GM) maize Mon 810. EuropaBio, the organization representing Europe's...

Cyprus/Greece/MaltaCyprusGreeceMalta

28.09.2005

Nicosia - US-based Genaissance Pharmaceuticals Inc. announced in September that it will provide its high-throughput genotyping services to Cyprus' Biotronics Ltd. Biotronics has been awarded a contract by the Veterinary Services...

Cyprus/Greece/MaltaCyprusGreeceMalta

12.08.2005

Athens - The Greek government announced in August a collaborative agreement between its contractor Antisel A. Selidis and US-based Genaissance Pharmaceuticals in the field of scrapie genotyping.Under the terms of the agreement,...

Cyprus/Greece/MaltaCyprusGreeceMalta

12.08.2005

La Valetta - After a broad discussion process Malta's Social Affairs Committee has presented a draft regulation on biotechnology and assisted reproduction to the parliament in July.According to the proposals the fertilised ovum...

Cyprus/Greece/MaltaCyprusGreeceMalta

10.07.2005

La Valletta - Synergene Biotechnology Group, a Malta-based biotech company, in line with its expansion programme has recently appointed several new members to the board of directors of Synergene Technologies Limited. The new...

Cyprus/Greece/MaltaCyprusGreeceMalta

10.07.2005

Valletta - In mid-June the Social Affairs Committee of the House of Representatives has ended its consultation process regarding the use of biotechnology in Malta. The Committee is currently discussing a report compiled by the...

Cyprus/Greece/MaltaCyprusGreeceMalta

10.05.2005

Athens - Greece supports the development of biotechnology but is wary of its side effects, Greek Development Minister Dimitris Sioufas said during the first national Greek biotechnology and food technology conference held on...

Cyprus/Greece/MaltaCyprusGreeceMalta

10.05.2005

Athens/Lugano - Helsinn Healthcare S.A., a Swiss pharmaceutical group, and Galenica, a Greek pharmaceutical company, announced recently the signing of an agreement granting Galenica the exclusive licence and distribution rights...

Displaying results 21 to 30 out of 48

< Previous 21-30 Next >

© 2007-2015 BIOCOM

http://www.european-biotechnology-news.com/news/messages-archive/archive-cyprus-greece-malta/browse/2.html

WhitePaper

LentiKat’s offers an unusual investment opportunity

LentiKat’s owns, manufactures and distributes a patented immobilization into lentil-shaped Lentikats Biocatalysts. The unique lentil-like shape of the Lentikats Biocatalyst ensures unlimited diffusion of substrate(s) into any part of the matrix, while still retaining a convenient size for easy separation from the reaction medium. They find application in the Pharma & Food industry (including bio-based chemicals), Wastewater treatment as well as Biofuels. more...

Product of the week

Products

Job Advert

Sales Manager

celares GmbH is a Berlin based drug delivery company focused on chemical modifications of biological drugs. We offer customized development services for international pharma and biopharma companies and have manufacturing capabilities for key starting materials used for the preparation of pharmaceutical drugs. For the intensification of our own sales activities we are looking for a sales manager. more...

Events

All Events

Partner-Events

München

BioVaria 2015

Stock list

All quotes

TOP

  • THERAMETRICS0.08 CHF14.29%
  • MEDIGENE10.96 EUR4.88%
  • EVOLVA1.58 CHF3.27%

FLOP

  • BIOTEST71.00 EUR-3.92%
  • SYNGENTA314.40 CHF-3.65%
  • 4SC5.03 EUR-3.27%

TOP

  • 4SC5.03 EUR293.0%
  • WILEX4.33 EUR51.4%
  • SARTORIUS151.00 EUR21.2%

FLOP

  • CYTOS1.01 CHF-29.4%
  • BIOTEST71.00 EUR-26.9%
  • BIOFRONTERA2.30 EUR-11.2%

TOP

  • SANTHERA96.45 CHF2329.5%
  • CYTOS1.01 CHF676.9%
  • WILEX4.33 EUR397.7%

FLOP

  • MOLOGEN4.94 EUR-55.4%
  • BIOFRONTERA2.30 EUR-29.2%
  • BIOTEST71.00 EUR-20.0%

No liability assumed, Date: 03.05.2015

Current issue

All issues